Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer

被引：5
|
作者：
Knoedler, M.
Gauler, T. C.
Matzdorff, A.
Dietz, A.
Gruenwald, V.
Arnold, D.
Hennemann, B.
Schroeder, M.
Hofele, C.
Schmittel, A.
Keilholz, U.
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Univ Klinikum Essen, Essen, Germany
[3] Caritasklin, Saarbrucken, Germany
[4] Univ Klinikum Leipzig, Leipzig, Germany
[5] Hannover Med Sch, D-30623 Hannover, Germany
[6] Univ Klinikum Halle, Halle, Germany
[7] Univ Klinikum Regensburg, Regensburg, Germany
[8] St Johannes Hosp Duisburg, Duisburg, Germany
[9] Univ Klinikum Heidelberg, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CETUXIMAB PLUS DOCETAXEL AS TREATMENT FOR RECURRENT AND/OR METASTATIC HEAD AND NECK CANCER
    Knoedler, M. K.
    Gauler, T. C.
    Matzdorff, A.
    Jordan, O.
    Schroeder, M.
    Gruenwald, V.
    Dietz, A.
    Hennemann, B.
    Arnold, D.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2008, 19 : 220 - 220
  • [2] Multicenter phase II study of cetuximab plus docetaxel in 84 patients with recurrent or metastatic, platinum-pretreated SCCHN
    Knoedler, M. K.
    Gauler, T.
    Matzdorff, A.
    Jordan, O.
    Schroeder, M.
    Gruenwald, V.
    Dietz, A.
    Arnold, D.
    Hennemann, B.
    Keilholz, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Phase II trial of cetuximab plus docetaxel in patients with relapsed head and neck carcinoma
    Knoedler, M.
    Na, I. -K.
    Rohde, M.
    Thiel, E.
    Schmittel, A.
    Keilholz, U.
    ONKOLOGIE, 2008, 31 : 110 - 110
  • [4] A randomized phase II trial of the MET inhibitor tivantinib plus cetuximab versus cetuximab alone in patients with recurrent/metastatic head and neck cancer
    Vokes, Everett E.
    Worden, Francis P.
    Adkins, Douglas
    Bauman, Julie E.
    Lim, Dean
    Sukari, Ammar
    Rao, Krishna A.
    Wagner, Stephanie Ann
    Curtis, Kelly Kevelin
    Gitlitz, Barbara J.
    Price, Katharine Andress Rowe
    Wade, James Lloyd
    Villaflor, Victoria Meucci
    De Souza, Jonas A.
    Karrison, Theodore
    Stadler, Walter Michael
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
    Jimenez, Begona
    Trigo, Jose M.
    Pajares, Bella I.
    Saez, Maria I.
    Quero, Cristina
    Navarro, Victor
    Llacer, Casilda
    Medina, Laura
    Rueda, Antonio
    Alba, Emilio
    ORAL ONCOLOGY, 2013, 49 (02) : 182 - 185
  • [6] A phase II trial of perifosine in patients with recurrent or metastatic head and neck cancer
    Argiris, A
    Cohen, EEW
    Wade, J
    Mauer, A
    Gustin, D
    Ansari, R
    Wong, S
    Karrison, T
    Vokes, E
    LUNG CANCER, 2004, 46 : S66 - S66
  • [7] Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
    Imamura, Yoshinori
    Tanaka, Kaoru
    Kiyota, Naomi
    Hayashi, Hidetoshi
    Ota, Ichiro
    Arai, Akihito
    Iwae, Shigemichi
    Minami, Shujiro
    Yane, Katsunari
    Yamazaki, Tomoko
    Nagatani, Yoshiaki
    Toyoda, Masanori
    Takahama, Takayuki
    Sakai, Kazuko
    Nishio, Kazuto
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minami, Hironobu
    MEDICAL ONCOLOGY, 2021, 38 (11)
  • [8] Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
    Yoshinori Imamura
    Kaoru Tanaka
    Naomi Kiyota
    Hidetoshi Hayashi
    Ichiro Ota
    Akihito Arai
    Shigemichi Iwae
    Shujiro Minami
    Katsunari Yane
    Tomoko Yamazaki
    Yoshiaki Nagatani
    Masanori Toyoda
    Takayuki Takahama
    Kazuko Sakai
    Kazuto Nishio
    Naoki Otsuki
    Ken-ichi Nibu
    Hironobu Minami
    Medical Oncology, 2021, 38
  • [9] Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
    Rivera, Fernando
    Garcia-Castano, Almudena
    Vega, Noelia
    Eugenia Vega-Villegas, M.
    Gutierrez-Sanz, Lourdes
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1421 - 1428
  • [10] A phase II trial evaluating weekly docetaxel and capacitabine in patients with metastatic or advanced, locally, recurrent head and neck cancer
    Zhang, J.
    Lee, J. S.
    Urba, S.
    Worden, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345